Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys
- PMID: 17640955
- DOI: 10.1124/dmd.107.016261
Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys
Abstract
Changes in ambient temperature are known to alter both the hyperthermic and the serotonergic consequences of 3,4-methylenedioxymethamphetamine (MDMA). Metabolism of MDMA has been suggested to be a requisite for these neurotoxic effects, whereas the hyperthermic response is an important contributing variable. The aim of the present study was to investigate the interaction between ambient temperature, MDMA-induced thermodysregulation, and its metabolic disposition in monkeys. MDMA (1.5 mg/kg i.v.) was administered noncontingently at cool (18 degrees C; n = 5), room (24 degrees C; n = 7), and warm (31 degrees C; n = 7) ambient temperatures. For 240 min following MDMA administration, core temperature was recorded and blood samples were collected for analysis of MDMA and its metabolites 3,4-dihydroxymethamphetamine (HHMA), 3,4-dihydroxyamphetamine, and 3,4-methylenedioxyamphetamine (MDA). A dose of 1.5 mg/kg MDMA induced a hypothermic response at 18 degrees C, a hyperthermic response at 31 degrees C, and did not significantly change core temperature at 24 degrees C. Regardless of ambient temperature, plasma MDMA concentrations reached maximum within 5 min, and HHMA was a major metabolite. Curiously, the approximate elimination half-life (t(1/2)) of MDMA at 18 degrees C (136 min) and 31 degrees C (144 min) was increased compared with 24 degrees C (90 min) and is most likely because of volume of distribution changes induced by core temperature alterations. At 18 degrees C, there was a significantly higher MDA area under the concentration-time curve (AUC) and a trend for a lower HHMA AUC compared with 24 degrees C and 31 degrees C, suggesting that MDMA disposition was altered. Overall, induction of hypothermia in a cool environment by MDMA may alter its disposition. These results could have implications for MDMA-induced serotonergic consequences.
Similar articles
-
Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.Drug Metab Dispos. 2009 Oct;37(10):2079-86. doi: 10.1124/dmd.109.028340. Epub 2009 Jul 23. Drug Metab Dispos. 2009. PMID: 19628751 Free PMC article.
-
The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.Br J Pharmacol. 1995 Aug;115(7):1281-9. doi: 10.1111/j.1476-5381.1995.tb15037.x. Br J Pharmacol. 1995. PMID: 7582557 Free PMC article.
-
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.Br J Pharmacol. 2014 Jan;171(1):83-91. doi: 10.1111/bph.12423. Br J Pharmacol. 2014. PMID: 24328722 Free PMC article.
-
The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.Br J Pharmacol. 2010 Jul;160(5):1029-44. doi: 10.1111/j.1476-5381.2010.00722.x. Br J Pharmacol. 2010. PMID: 20590597 Free PMC article. Review.
-
A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.Eur J Pharmacol. 2004 Oct 1;500(1-3):3-13. doi: 10.1016/j.ejphar.2004.07.006. Eur J Pharmacol. 2004. PMID: 15464016 Review.
Cited by
-
Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.Drug Metab Dispos. 2009 Oct;37(10):2079-86. doi: 10.1124/dmd.109.028340. Epub 2009 Jul 23. Drug Metab Dispos. 2009. PMID: 19628751 Free PMC article.
-
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.Neuroscience. 2012 Jan 10;201:125-33. doi: 10.1016/j.neuroscience.2011.11.040. Epub 2011 Nov 29. Neuroscience. 2012. PMID: 22138434 Free PMC article.
-
M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.Neurotoxicology. 2019 Sep;74:91-99. doi: 10.1016/j.neuro.2019.05.011. Epub 2019 Jun 1. Neurotoxicology. 2019. PMID: 31163210 Free PMC article.
-
Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys.Behav Pharmacol. 2008 Mar;19(2):167-70. doi: 10.1097/FBP.0b013e3282f62c40. Behav Pharmacol. 2008. PMID: 18332682 Free PMC article.
-
Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.Ann N Y Acad Sci. 2008 Oct;1141:176-94. doi: 10.1196/annals.1441.023. Ann N Y Acad Sci. 2008. PMID: 18991958 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical